JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
🇮🇱📄

Domestic Product Registration

IMFA product registration and domestic patient access

Product Registration Verified 2026-04-20

Workflow steps

  1. Product for Israeli Market
    Product intended for the Israeli domestic medical cannabis market. IMFA maintains a product registry — all domestically sold products must be registered.
  2. Hold IMCA Manufacturing License
    IMFA-issued IMCA license with manufacturing scope required. License specifies permitted product forms (dried flower, extract, oil, capsule, etc.).
    • IMCA manufacturing license
    • Product forms must match license scope
    • Facility must pass IMFA GMP inspection
  3. Prepare Product Dossier
    IMFA requires product specifications, analytical methods, stability data, and GMP documentation for each registered product.
    • Product name, form, THC/CBD content
    • Batch manufacturing record template
    • Analytical specifications (HPLC, microbiology)
    • Stability data per IMFA guidance
    • Labeling in Hebrew (mandatory)
  4. IMFA Product Registration
    Submit product dossier to IMFA for registration. IMFA assigns a registration number. Processing: 4–12 weeks for new products.
  5. Registration granted?
    IMFA approves or requests additional information. Common issues: stability data gaps, labeling non-compliance, or analytical method validation gaps.
  6. Address IMFA Queries
    Provide additional stability data, analytical method validation reports, or revised labeling as requested.
    • Respond within IMFA-specified timeframe
    • Updated labeling must comply with IMFA labeling directive
  7. Product Registered
    IMFA registration number issued. Product may be supplied to licensed dispensaries and pharmacies.
    • Registration number on all product labeling
    • Annual renewal of registration required
    • Any formulation changes require IMFA variation approval
  8. Patient Quota System
    Israeli patients receive a monthly gram quota from MOH. Products are prescribed against this quota. IMFA tracks supply chain from manufacturer to patient via electronic system.
    • IMFA electronic tracking system compliance
    • Monthly reporting to IMFA
    • Quota changes require MOH approval
  9. Domestic Supply Active ✓
    Product available to ~120,000 licensed Israeli patients via IMFA-licensed dispensaries and pharmacies.
GMP PathwayImport into Israel